GR880300043T1 - Process for the purification of bordetella bacteria proteic antigens for the obtention of an acellular vaccine - Google Patents

Process for the purification of bordetella bacteria proteic antigens for the obtention of an acellular vaccine

Info

Publication number
GR880300043T1
GR880300043T1 GR88300043T GR880300043T GR880300043T1 GR 880300043 T1 GR880300043 T1 GR 880300043T1 GR 88300043 T GR88300043 T GR 88300043T GR 880300043 T GR880300043 T GR 880300043T GR 880300043 T1 GR880300043 T1 GR 880300043T1
Authority
GR
Greece
Prior art keywords
purification
antigens
obtention
proteic
acellular vaccine
Prior art date
Application number
GR88300043T
Other languages
English (en)
Inventor
Quentin-Millet Marie-Jose
Arminjon Francois
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of GR880300043T1 publication Critical patent/GR880300043T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
GR88300043T 1986-04-16 1988-05-20 Process for the purification of bordetella bacteria proteic antigens for the obtention of an acellular vaccine GR880300043T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8605456A FR2597344B1 (fr) 1986-04-16 1986-04-16 Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.

Publications (1)

Publication Number Publication Date
GR880300043T1 true GR880300043T1 (en) 1988-10-18

Family

ID=9334300

Family Applications (2)

Application Number Title Priority Date Filing Date
GR88300043T GR880300043T1 (en) 1986-04-16 1988-05-20 Process for the purification of bordetella bacteria proteic antigens for the obtention of an acellular vaccine
GR930400091T GR3006840T3 (el) 1986-04-16 1993-01-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR930400091T GR3006840T3 (el) 1986-04-16 1993-01-21

Country Status (12)

Country Link
US (1) US4774086A (el)
EP (1) EP0242301B1 (el)
JP (3) JP2563797B2 (el)
AT (1) ATE81782T1 (el)
AU (1) AU601415B2 (el)
CA (1) CA1328070C (el)
DE (3) DE3782356T2 (el)
ES (1) ES2000435T3 (el)
FR (1) FR2597344B1 (el)
GR (2) GR880300043T1 (el)
LU (1) LU90378I2 (el)
ZA (1) ZA872712B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
US5032398A (en) * 1986-08-01 1991-07-16 Kaslow Harvey R Selective modification of the catalytic subunit of pertussis toxin
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) * 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4500639A (en) * 1981-10-15 1985-02-19 Teijin Limited Culturing Bordetella in media containing etherified cyclodextrin
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Lpf−haの精製法
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
JPS60237027A (ja) * 1984-05-07 1985-11-25 Chemo Sero Therapeut Res Inst 線維状赤血球凝集素の精製方法
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine

Also Published As

Publication number Publication date
FR2597344A1 (fr) 1987-10-23
DE19875021I2 (de) 2010-07-01
DE3782356T2 (de) 1993-04-29
JP2563797B2 (ja) 1996-12-18
JPS62258326A (ja) 1987-11-10
JP2599259B2 (ja) 1997-04-09
ZA872712B (en) 1987-10-05
DE3782356D1 (de) 1992-12-03
JPH08225463A (ja) 1996-09-03
CA1328070C (fr) 1994-03-29
ATE81782T1 (de) 1992-11-15
LU90378I2 (fr) 1999-05-31
US4774086A (en) 1988-09-27
AU601415B2 (en) 1990-09-13
EP0242301B1 (fr) 1992-10-28
FR2597344B1 (fr) 1989-06-23
JP2599260B2 (ja) 1997-04-09
GR3006840T3 (el) 1993-06-30
JPH08231421A (ja) 1996-09-10
ES2000435A4 (es) 1988-03-01
AU7158187A (en) 1987-10-22
EP0242301A1 (fr) 1987-10-21
ES2000435T3 (es) 1994-02-01
DE242301T1 (de) 1988-06-09

Similar Documents

Publication Publication Date Title
DK512686A (da) Thrombinpraeparater, deres fremstilling og anvendelse
PT77515A (en) Immunogenic protein or peptide complex method of producing said complex and use thereof as an immune stimulant and as a vaccine
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
GR880300043T1 (en) Process for the purification of bordetella bacteria proteic antigens for the obtention of an acellular vaccine
ES8606485A1 (es) Procedimiento para preparar una solucion antigenica libre decelulas
DE3582737D1 (de) Verfahren zur herstellung von 6-hydroxynikotinsaeure.
DE69527986T2 (de) Antigene arznei zur behandlung oder vorbeugung
ZA874064B (en) Method of preparing toxoid
IL113595A0 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
GB9201013D0 (en) Vaccines
ES8407094A1 (es) Un procedimiento de produccion de glucosa deshidrogenasa.
HUT48200A (en) Process for producing 2,6-difluorobenzamide
ZA862478B (el)
FR2700172B1 (fr) Procede de culture de bacteries filamenteuses non photosynthetiques et non fructifiantes.
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
ATE87658T1 (de) Verfahren zur selektiven biokonversion von isosorbid-dinitrat.
PT82373A (en) Process for preparing a klebsiella capsular polysaccharide vaccine
MX9708480A (es) Vacunas acelulares de pertussis y metodos de preparacion de las mismas.